ATE491696T1 - Neue 2,4-diaminothiazol-5-onderivate - Google Patents
Neue 2,4-diaminothiazol-5-onderivateInfo
- Publication number
- ATE491696T1 ATE491696T1 AT05759691T AT05759691T ATE491696T1 AT E491696 T1 ATE491696 T1 AT E491696T1 AT 05759691 T AT05759691 T AT 05759691T AT 05759691 T AT05759691 T AT 05759691T AT E491696 T1 ATE491696 T1 AT E491696T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- derivatives
- novel
- treatment
- disclosed
- Prior art date
Links
- BLPGWIBMZNEFCR-UHFFFAOYSA-N 2,4-diamino-2h-1,3-thiazol-5-one Chemical class NC1SC(=O)C(N)=N1 BLPGWIBMZNEFCR-UHFFFAOYSA-N 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- QHHHLHCCVDMOJI-UHFFFAOYSA-N 1,3-thiazol-4-amine Chemical class NC1=CSC=N1 QHHHLHCCVDMOJI-UHFFFAOYSA-N 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 108091007914 CDKs Proteins 0.000 abstract 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 abstract 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 abstract 1
- 230000001028 anti-proliverative effect Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 208000029742 colonic neoplasm Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 208000037841 lung tumor Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000023958 prostate neoplasm Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58818404P | 2004-07-15 | 2004-07-15 | |
| PCT/EP2005/007342 WO2006005508A1 (en) | 2004-07-15 | 2005-07-07 | Novel 2,4-diaminothiazol-5-one derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE491696T1 true ATE491696T1 (de) | 2011-01-15 |
Family
ID=35115799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05759691T ATE491696T1 (de) | 2004-07-15 | 2005-07-07 | Neue 2,4-diaminothiazol-5-onderivate |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7423053B2 (de) |
| EP (1) | EP1771424B1 (de) |
| JP (1) | JP2008505950A (de) |
| KR (1) | KR100908591B1 (de) |
| CN (1) | CN1976910B (de) |
| AT (1) | ATE491696T1 (de) |
| AU (1) | AU2005261954A1 (de) |
| BR (1) | BRPI0511826A (de) |
| CA (1) | CA2573603A1 (de) |
| DE (1) | DE602005025357D1 (de) |
| MX (1) | MX2007000425A (de) |
| RU (1) | RU2395501C2 (de) |
| WO (1) | WO2006005508A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8486967B2 (en) * | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
| WO2018089902A1 (en) * | 2016-11-13 | 2018-05-17 | Apogee Biotechnology Corporation | Diaminothiazole compounds, compositions and methods of use |
| CN114306255B (zh) * | 2021-12-30 | 2023-05-23 | 北京鑫开元医药科技有限公司 | 一种甲基酮类衍生物药物制剂及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2728901B1 (fr) * | 1994-12-28 | 1997-03-28 | Sanofi Sa | Derives de phenyl-4-thiazoles substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
| PL342447A1 (en) * | 1997-10-27 | 2001-06-04 | Agouron Pharma | Substituted 4-amino thiazol-2-yl compounds as inhibitors of cyclin-dependent kinases |
| US6262096B1 (en) * | 1997-11-12 | 2001-07-17 | Bristol-Myers Squibb Company | Aminothiazole inhibitors of cyclin dependent kinases |
| US7169778B2 (en) | 1999-09-15 | 2007-01-30 | Warner-Lambert Company | Pteridinones as kinase inhibitors |
| EP1235815A1 (de) | 1999-11-22 | 2002-09-04 | Warner-Lambert Company | Chinazoline und ihre verwendung als cyclin-dependent kinase enzym- inhibitoren |
| AU2001230026A1 (en) | 2000-02-04 | 2001-08-14 | Novo-Nordisk A/S | 2,4-diaminothiazole derivatives |
| MXPA02010222A (es) | 2000-04-18 | 2003-05-23 | Agouron Pharma | Pirazoles para inhibir proteina cinasa. |
| HN2002000156A (es) * | 2001-07-06 | 2003-11-27 | Inc Agouron Pharmaceuticals | Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización. |
| HUP0401403A3 (en) | 2001-08-03 | 2005-11-28 | Novo Nordisk As | 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them |
| MXPA05008520A (es) * | 2003-02-12 | 2005-10-20 | Pfizer | Derivados de 2-(sulfo-fenil)-aminotiazol antiproliferativos. |
| MXPA05008878A (es) * | 2003-02-21 | 2005-10-05 | Pfizer | Derivados de aminotiazol sustituidos con cicloalquilo que contiene n y composiciones farmaceuticas para inhibir la proliferacion celular, y metodos para su uso. |
| US7211576B2 (en) * | 2004-04-20 | 2007-05-01 | Hoffmann-La Roche Inc. | Diaminothiazoles |
-
2005
- 2005-06-29 US US11/170,636 patent/US7423053B2/en not_active Expired - Fee Related
- 2005-07-07 BR BRPI0511826-3A patent/BRPI0511826A/pt not_active IP Right Cessation
- 2005-07-07 MX MX2007000425A patent/MX2007000425A/es active IP Right Grant
- 2005-07-07 JP JP2007520717A patent/JP2008505950A/ja active Pending
- 2005-07-07 AU AU2005261954A patent/AU2005261954A1/en not_active Abandoned
- 2005-07-07 CA CA002573603A patent/CA2573603A1/en not_active Abandoned
- 2005-07-07 KR KR1020077000842A patent/KR100908591B1/ko not_active Expired - Fee Related
- 2005-07-07 DE DE602005025357T patent/DE602005025357D1/de not_active Expired - Lifetime
- 2005-07-07 RU RU2007105557/04A patent/RU2395501C2/ru not_active IP Right Cessation
- 2005-07-07 EP EP05759691A patent/EP1771424B1/de not_active Expired - Lifetime
- 2005-07-07 WO PCT/EP2005/007342 patent/WO2006005508A1/en not_active Ceased
- 2005-07-07 AT AT05759691T patent/ATE491696T1/de not_active IP Right Cessation
- 2005-07-07 CN CN2005800216787A patent/CN1976910B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006005508A1 (en) | 2006-01-19 |
| BRPI0511826A (pt) | 2007-12-26 |
| EP1771424B1 (de) | 2010-12-15 |
| KR20070020557A (ko) | 2007-02-21 |
| US20060014958A1 (en) | 2006-01-19 |
| CN1976910A (zh) | 2007-06-06 |
| AU2005261954A1 (en) | 2006-01-19 |
| CN1976910B (zh) | 2010-07-21 |
| JP2008505950A (ja) | 2008-02-28 |
| DE602005025357D1 (de) | 2011-01-27 |
| RU2395501C2 (ru) | 2010-07-27 |
| MX2007000425A (es) | 2007-03-07 |
| CA2573603A1 (en) | 2006-01-19 |
| RU2007105557A (ru) | 2008-08-20 |
| US7423053B2 (en) | 2008-09-09 |
| KR100908591B1 (ko) | 2009-07-22 |
| EP1771424A1 (de) | 2007-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0511975A (pt) | pirazolopirimidinas | |
| BRPI0513836A (pt) | composto, métodos de tratar, controlar ou prevenir cáncer, uma doença associada com angiogênese indesejada, e uma doença ou distúrbio mediado por pde 4, e de reduzir ou inibir o nìvel ou a atividade de pde 4 em um paciente, e, composição farmacêutica | |
| ATE453636T1 (de) | Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren | |
| EE200200123A (et) | Türosiinkinaasi pärssiv ühend, seda sisaldav farmatseutiline kompositsioon ning raviotstarbeline kasutamine | |
| EA201400111A1 (ru) | Ингибиторы mek и способы их применения | |
| WO2006081230A3 (en) | 3-(indazol-5-yl)-(1,2, 4) triazine derivatives and related compounds as protein kinase inhibitors for the treatment of cancer | |
| NO20075849L (no) | Fremgangsmater og preparater til behandling eller forebygging av kreft | |
| DE60215682D1 (de) | AZAOXOINDOL DERIVATE ALS Trk PROTEIN KINASE HEMMSTOFFE ZUR BEHANDLUNG VON KREBS UND CHRONISCHEM SCHMERZ | |
| PE20050523A1 (es) | Pirazoles como inhidores de factor de necrosis tumoral | |
| TW200724543A (en) | Heterocyclic compounds and their uses as therapeutic agents | |
| TNSN05188A1 (en) | 4-aminopyrimidine-5-one | |
| PL1809288T3 (pl) | Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych | |
| TW200612929A (en) | Novel 2,6-diaminopyridine-3-one derivatives | |
| ATE435224T1 (de) | Neue piperidinsubstituierte diaminothiazole | |
| ATE491696T1 (de) | Neue 2,4-diaminothiazol-5-onderivate | |
| ATE367825T1 (de) | Zusammensetzung und kit zur verwendung in der tumorbehandlung | |
| DE602004009097D1 (de) | 1.3.4-triaza-phenalen- und 1,3,4,6-tetraazaphenalen-derivative | |
| BRPI0815334A2 (pt) | derivados de pirazolo[3,4-d]-piramidina como agentes antiproliferativos | |
| HRP20080422T3 (hr) | Satraplatin za liječenje rezistentnih ili refraktornih tumora | |
| DE60305520D1 (de) | 2" oxo-voruscharin und derivaten | |
| ATE432933T1 (de) | Flavopereirinderivate zur krebstherapie | |
| DE502004008294D1 (de) | Neue makrocyclen zur behandlung von krebserkrankungen | |
| UY27131A1 (es) | Diaminotiazoles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |